Authors:
, , , , , , and
Authors:
,
,
,
,
,
,
, and
Ting Fu
Ting Fu
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Ting Fu in
Current site
Google Scholar
PubMed
Search for other papers by Ting Fu in
Current site
Google Scholar
PubMed
Eva B. Znalesniak
Eva B. Znalesniak
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Eva B. Znalesniak in
Current site
Google Scholar
PubMed
Search for other papers by Eva B. Znalesniak in
Current site
Google Scholar
PubMed
Thomas Kalinski
Thomas Kalinski
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Thomas Kalinski in
Current site
Google Scholar
PubMed
Search for other papers by Thomas Kalinski in
Current site
Google Scholar
PubMed
Luisa Möhle
Luisa Möhle
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Luisa Möhle in
Current site
Google Scholar
PubMed
Search for other papers by Luisa Möhle in
Current site
Google Scholar
PubMed
Aindrila Biswas
Aindrila Biswas
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Aindrila Biswas in
Current site
Google Scholar
PubMed
Search for other papers by Aindrila Biswas in
Current site
Google Scholar
PubMed
Franz Salm
Franz Salm
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Franz Salm in
Current site
Google Scholar
PubMed
Search for other papers by Franz Salm in
Current site
Google Scholar
PubMed
Ildiko Rita Dunay
Ildiko Rita Dunay
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Ildiko Rita Dunay in
Current site
Google Scholar
PubMed
Search for other papers by Ildiko Rita Dunay in
Current site
Google Scholar
PubMed
Werner Hoffmann
Werner Hoffmann
Otto-von-Guericke University Magdeburg, Germany
Search for other papers by Werner Hoffmann in
Current site
Google Scholar
PubMed
Search for other papers by Werner Hoffmann in
Current site
Google Scholar
PubMed
The peptide trefoil factor family 3 (TFF3) is a major constituent of the intestinal mucus, playing an important role in the repair of epithelial surfaces. To further understand the role of TFF3 in the protection of intestinal epithelium, we tested the influence of TFF3 in a murine Toxoplasma gondii-induced ileitis model. Surprisingly, TFF3KO mice showed a reduced immune response in the ileum when compared to wild-type animals. Interleukin-12 and interferon-γ expression levels as well as the number of CD4+ lymphocytes were reduced in the infected TFF3KO mice. These effects were in line with the trend of elevated parasite levels in the ileum. Moreover, TFF1 expression was upregulated in the spleen of infected mice. These initial results indicate that TFF3 is involved in the immune pathology of T. gondii infection-induced intestinal inflammation. Thus far, the mechanisms of how TFF3 influences the immune response are not fully understood. Further studies should identify if TFF3 affects mucus sensing of dendritic cells and how TFF3 is involved in regulating the immune response as an intrinsic secretory peptide of immune cells.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Hoffmann W (2013): TFF Peptides. In: Handbook of Biologically Active Peptides (2nd edition), ed. Kastin AJ, Elsevier, San Diego, pp. 1338–1345
-
2.
Kjellev S : The trefoil factor family –small peptides with multiple functionalities. Cell Mol Life Sci 66, 1350–1369 (2009)
-
3.
Hoffmann W , Jagla W: Cell type specific expression of secretory TFF peptides: Colocalization with mucins and synthesis in the brain. Int Rev Cytol 213, 147–181 (2002)
-
4.
Suemori S , Lynch-Devaney K, Podolsky DK: Identification and characterization of rat intestinal trefoil factor: Tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A 88, 11017–110721 (1991)
-
5.
Hauser F , Poulsom R, Chinery R, Rogers LA, Hanby AM, Wright NA, Hoffmann, W: hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A 90, 6961–6965 (1993)
-
6.
Matsuoka Y , Pascall JC, Brown KD: Quantitative analysis reveals differential expression of mucin (MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine. Biochim Biophys Acta 1489, 336–344 (1999)
-
7.
Albert TK , Laubinger W, Müller S, Hanisch FG, Kalinski T, Meyer F, Hoffmann, W: Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-associated FCGBP protein and is released by hydrogen sulfide. J Proteome Res 9, 3108–3117 (2010)
-
8.
Kouznetsova I , Gerlach KL, Zahl C, Hoffmann W: Expression analysis of human salivary glands by laser microdissection: Differences between submandibular and labial glands. Cell Physiol Biochem 26, 375–382 (2010)
-
9.
Kouznetsova I , Kalinski T, Peitz U, Mönkemüller KE, Kalbacher H, Vieth M, Meyer F, Roessner A, Malfertheiner P, Lippert H, Hoffmann W: Localization of TFF3 peptide in human esophageal submucosal glands and gastric cardia: Differentiation of two types of gastric pit cells along the rostro-caudal axis. Cell Tissue Res 328, 365–374 (2007)
-
10.
Kouznetsova I , Peitz U, Vieth M, Meyer F, Vestergaard EM, Malfertheiner P, Roessner A, Lippert H, Hoffmann W: A gradient of TFF3 (trefoil factor family 3) peptide synthesis within the normal human gastric mucosa. Cell Tissue Res 316, 155–165 (2004)
-
11.
Paulsen F , Varoga D, Paulsen A, Tsokos M: Trefoil factor family (TFF) peptides of normal human Vater’s ampulla. Cell Tissue Res 321, 67–74 (2005)
-
12.
Wiede A , Jagla W, Welte T, Köhnlein T, Busk H, Hoffmann W: Localization of TFF3, a new mucus-associated peptide of the human respiratory tract. Am J Respir Crit Care Med 159, 1330–1335 (1999)
-
13.
Wiede A , Hinz M, Canzler E, Franke K, Quednow C, Hoffmann W: Synthesis and localization of the mucin-associated TFF-peptides in the human uterus. Cell Tissue Res 303, 109–115 (2001)
-
14.
Madsen J , Nielsen O, Tornøe I, Thim L, Holmskov U: Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem 55, 505–513 (2007)
-
15.
Rinnert M , Hinz M, Buhtz P, Reiher F, Lessel W, Hoffmann W: Synthesis and localization of trefoil factor family (TFF) peptides in the human urinary tract and TFF2 excretion into the urine. Cell Tissue Res 339, 639–647 (2010)
-
16.
Langer G , Jagla W, Behrens-Baumann W, Walter S, Hoffmann W: Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells. Invest Ophthalmol Vis Sci 40, 2220–2224 (1999)
-
17.
Paulsen FP , Hinz M, Schaudig U, Thale AB, Hoffmann W: TFF peptides in the human efferent tear ducts. Invest Ophthalmol Vis Sci 43, 3359–3364 (2002)
-
18.
Jackerott M , Lee YC, Møllgård K, Kofod H, Jensen J, Rohleder S, Neubauer N, Gaarn LW, Lykke J, Dodge R, Dalgaard LT, Søstrup B, Jensen DB, Thim L, Nexø E, Thams P, Bisgaard HC, Nielsen JH: Trefoil factors are expressed in human and rat endocrine pancreas: differential regulation by growth hormone. Endocrinology 147, 5752–5759 (2006)
-
19.
Jagla W , Wiede A, Dietzmann K, Rutkowski K, Hoffmann W: Co-localization of TFF3 peptide and oxytocin in the human hypothalamus. FASEB J 14, 1126–1131 (2000)
-
20.
Fu T , Stellmacher A, Znalesniak EB, Dieterich DC, Kalbacher H, Hoffmann W: TFF3 is expressed in neurons and microglial cells. Cell Physiol Biochem 34, 1912–1919 (2014)
-
21.
Bernstein HG , Dobrowolny H, Trübner K, Steiner J, Bogerts B, Hoffmann W: Differential regional and cellular distribution of TFF3 peptide in the human brain. Amino Acids 47, 1053–1063 (2015)
-
22.
Cook GA , Familari M, Thim L, Giraud AS: The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response. FEBS Lett 456, 155–159 (1999)
-
23.
Teng X , Xu LF, Zhou P, Sun HW, Sun M: Effects of trefoil peptide 3 on expression of TNF-a, TLR4, and NF-?B in trinitrobenzene sulphonic acid induced colitis mice. Inflammation 32, 120–129 (2009)
-
24.
Poulsen SS , Kissow H, Hare K, Hartmann B, Thim L: Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat. Regul Pept 126, 163–171 (2005)
-
25.
Marchbank T , Cox HM, Goodlad RA, Giraud AS, Moss SF, Poulsom R, Wright NA, Jankowski J, Playford RJ: Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem 276, 24088–24096 (2001)
-
26.
Vandenbroucke K , Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, Rottiers P, Steidler L: Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127, 502–513 (2004)
-
27.
Mashimo H , Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274, 262–265 (1996)
-
28.
Beck PL , Wong JF, Li Y, Swaminathan S, Xavier RJ, Devaney KL, Podolsky DK: Chemotherapy- and radiotherapy- induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 126, 796–808 (2004)
-
29.
Chwieralski CE , Schnurra I, Thim L, Hoffmann W: Epidermal growth factor and trefoil factor family 2 synergistically trigger chemotaxis on BEAS-2B cells via different signaling cascades. Am J Respir Cell Mol Biol 31, 528–537 (2004)
-
30.
Taupin DR , Kinoshita K, Podolsky DK: Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A 97, 799–804 (2000)
-
31.
Rösler S , Haase T, Claassen H, Schulze U, Schicht M, Riemann D, Brandt J, Wohlrab D, Müller-Hilke B, Goldring MB, Sel S, Varoga D, Garreis F, Paulsen FP: Trefoil factor 3 is induced during degenerative and inflammatory joint disease, activates matrix metalloproteinases, and enhances apoptosis of articular cartilage chondrocytes. Arthritis Rheum 62, 815–825 (2010)
-
32.
Hoffmann W : Trefoil factor family (TFF) peptides and chemokine receptors: A promising relationship. J Med Chem 52, 6505–6510 (2009)
-
33.
Madsen J , Sorensen GL, Nielsen O, Tornøe I, Thim L, Fenger C, Mollenhauer J, Holmskov U: A variant form of the human deleted in malignant brain tumor 1 (DMBT1) gene shows increased expression in inflammatory bowel diseases and interacts with dimeric trefoil factor 3 (TFF3). PloS One 8, e64441 (2013)
-
34.
Reeves EP , Ali T, Leonard P, Hearty S, O’Kennedy R, May FE, Westley BR, Josenhans C, Rust M, Suerbaum S, Smith A, Drumm B, Clyne M: Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Gastroenterology 135, 2043–2054 (2008)
-
35.
Stürmer R , Müller S, Hanisch FG, Hoffmann W: Porcine gastric TFF2 is a mucus constituent and differs from pancreatic TFF2. Cell Physiol Biochem 33, 895–904 (2014)
-
36.
Hanisch FG , Bonar D, Schloerer N, Schroten H: Human trefoil factor 2 is a lectin that binds a-GlcNAc-capped mucin glycans with antibiotic activity against Helicobacter pylori. J Biol Chem 289, 27363–27375 (2014)
-
37.
Wright NA : Aspects of the biology of regeneration and repair in the human gastrointestinal tract. Philos Trans R Soc Lond B Biol Sci 353, 925–933 (1998)
-
38.
Furuta GT , Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP: Hypoxiainducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193, 1027–1034 (2001)
-
39.
Podolsky DK , Gerken G, Eyking A, Cario E: Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 137, 209–220 (2009)
-
40.
Riaño A , Ortiz-Masià D, Velázquez M, Calatayud S, Esplugues JV, Barrachina MD: Nitric oxide induces HIF-1a stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing. J Gastroenterol 46, 565–576 (2011)
-
41.
Johansson ME , Thomsson KA, Hansson GC: Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J Proteome Res 8, 3549–3557 (2009)
-
42.
Yu H , He Y, Zhang X, Peng Z, Yang Y, Zhu R, Bai J, Tian Y, Li X, Chen W, Fang D, Wang R: The rat IgGFcgammaBP and Muc2 C-terminal domains and TFF3 in two intestinal mucus layers bind together by covalent interaction. PloS One 6, e20334 (2011)
-
43.
Kindon H , Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK: Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 109, 516–523 (1995)
-
44.
Johansson ME , Sjövall H, Hansson GC: The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10, 352–361 (2013)
-
45.
Hoffmann W : TFF2, a MUC6-binding lectin stabilizing the gastric mucus barrier and more. Int J Oncol 47, 806–816 (2015)
-
46.
Johansson ME , Hansson GC: Keeping bacteria at a distance. Science 334, 182–183 (2011)
-
47.
Chen GY , Stappenbeck TS: Mucus, it is not just a static barrier. Sci Signal 7, pe11 (2014)
-
48.
Wlodarska M , Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E, Finlay BB, Flavell RA: NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156, 1045–1059 (2014)
-
49.
Patel KK , Miyoshi H, Beatty WL, Head RD, Malvin NP, Cadwell K, Guan JL, Saitoh T, Akira S, Seglen PO, Dinauer MC, Virgin HW, Stappenbeck TS: Autophagy proteins control goblet cell function by potentiating reactive oxygen species production. EMBO J 32, 3130–3144 (2013)
-
50.
Shan M , Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, He B, Cassis L, Bigas A, Cols M, Comerma L, Huang B, Blander JM, Xiong H, Mayer L, Berin C, Augenlicht LH, Velcich A, Cerutti A: Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342, 447–453 (2013)
-
51.
Belkaid Y , Grainger J: Mucus coat, a dress code for tolerance. Science 342, 432–433 (2013)
-
52.
Dunay IR , Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD: Gr1+ inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 29, 306–317 (2008)
-
53.
Heimesaat MM , Dunay IR, Schulze S, Fischer A, Grundmann U, Alutis M, Kühl AA, Tamas A, Toth G, Dunay MP, Göbel UB, Reglodi D, Bereswill S: Pituitary adenylate cyclase- activating polypeptide ameliorates experimental acute ileitis and extra-intestinal sequelae. PloS One 9, e108389 (2014)
-
54.
Kasper L , Courret N, Darche S, Luangsay S, Mennechet F, Minns L, Rachinel N, Ronet C, Buzoni-Gatel D: Toxoplasma gondii and mucosal immunity. Int J Parasitol 34, 401–409 (2004)
-
55.
Dunay IR , Sibley LD: Monocytes mediate mucosal immunity to Toxoplasma gondii. Curr Opin Immunol 22, 461–466 (2010)
-
56.
Mashayekhi M , Sandau MM, Dunay IR, Frickel EM, Khan A, Goldszmid RS, Sher A, Ploegh HL, Murphy TL, Sibley LD, Murphy KM: CD8a+ dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35, 249–259 (2011)
-
57.
Biswas A , Bruder D, Wolf SA, Jeron A, Mack M, Heimesaat MM, Dunay IR: Ly6Chigh monocytes control cerebral toxoplasmosis. J Immunol 194, 3223–3235 (2015)
-
58.
Dunay IR , Fuchs A, Sibley LD: Inflammatory monocytes but not neutrophils are necessary to control infection with Toxoplasma gondii in mice. Infect Immun 78, 1564–1570 (2010)
-
59.
McBerry C , Egan CE, Rani R, Yang Y, Wu D, Boespflug N, Boon L, Butcher B, Mirpuri J, Hogan SP, Denkers EY, Aliberti J, Herbert DR: Trefoil factor 2 negatively regulates type 1 immunity against Toxoplasma gondii. J Immunol 189, 3078–3084 (2012)
-
60.
Wills-Karp M , Rani R, Dienger K, Lewkowich I, Fox JG, Perkins C, Lewis L, Finkelman FD, Smith DE, Bryce PJ, Kurt-Jones EA, Wang TC, Sivaprasad U, Hershey GK, Herbert DR: Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection. J Exp Med 209, 607–622 (2012)
-
61.
Lubka M , Müller M, Baus-Loncar M, Hinz M, Blaschke K, Hoffmann W, Pfister M, Löwenheim H, Pusch CM, Knipper M, Blin N: Lack of TFF3 peptide results in hearing impairment and accelerated presbyacusis. Cell Physiol Biochem 21, 437–444 (2008)
-
62.
Blaschke K : Vergleichende neurobiologische Untersuchungen von TFF3-defizienten Mäusen und Wildtyptieren (MD Thesis). Medical Faculty, Otto-von-Guericke-Universität Magdeburg (2010)
-
63.
Fu T : In vivo and in vitro studies on the expression and function of TFF peptides in the gastrointestinal tract and the central nervous system. Fakultät für Naturwissen schaften, Otto-von-Guericke-Universität Magdeburg (2014)
-
64.
Fu T , Kalbacher H, Hoffmann W: TFF1 is differentially expressed in stationary and migratory rat gastric epithelial cells (RGM-1) after in vitro wounding: influence of TFF1 RNA interference on cell migration. Cell Physiol Biochem 32, 997–1010 (2013)
-
65.
Kouznetsova I , Chwieralski CE, Bälder R, Hinz M, Braun A, Krug N, Hoffmann W: Induced trefoil factor family 1 expression by trans-differentiating Clara cells in a murine asthma model. Am J Respir Cell Mol Biol 36, 286–295 (2007)
-
66.
Heimesaat MM , Dunay IR, Alutis M, Fischer A, Möhle L, Göbel UB, Kühl AA, Bereswill S. Nucleotide-oligomerization- domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis. PloS One 9, e105120 (2014)
-
67.
Baus-Loncar M , Kayademir T, Takaishi S, Wang T: Trefoil factor family 2 deficiency and immune response. Cell Mol Life Sci 62, 2947–2955 (2005)
-
68.
Kurt-Jones EA , Cao L, Sandor F, Rogers AB, Whary MT, Nambiar PR, Cerny A, Bowen G, Yan J, Takaishi S, Chi AL, Reed G, Houghton J, Fox JG, Wang TC: Trefoil family factor 2 is expressed in murine gastric and immune cells and controls both gastrointestinal inflammation and systemic immune responses. Infect Immun 75, 471–480 (2007)
Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildiko.dunay@med.ovgu.de
Indexing and Abstracting Services:
- PubMed Central
- Scopus
- ESCI
- CABI
- CABELLS Journalytics
| 2023 | |
|---|---|
| Web of Science | |
| Total Cites WoS |
674 |
| Journal Impact Factor | 3.3 |
| Rank by Impact Factor |
Q2 |
| Impact Factor without Journal Self Cites |
3.1 |
| 5 Year Impact Factor |
3.2 |
| Scimago | |
| Scimago H-index |
15 |
| Scimago Journal Rank |
0.601 |
| Scimago Quartile Score | Microbiology (medical) (Q2) Microbiology (Q3) Immunology and Allergy (Q3) Immunology (Q3) |
| Scopus | |
| Scopus Cite Score |
5.0 |
| Scopus CIte Score Rank |
Microbiology (medical) Q2 |
| Scopus SNIP |
0.832 |
| European Journal of Microbiology and Immunology | |
|---|---|
| Publication Model | Gold Open Access Online only |
| Submission Fee | none |
| Article Processing Charge | 900 EUR/article |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription Information | Gold Open Access |
| Purchase per Title | |
| European Journal of Microbiology and Immunology | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
2011 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Akadémiai Kiadó |
| Founder's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 2062-509X (Print) |
| ISSN | 2062-8633 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Sep 2024 | 0 | 71 | 5 |
| Oct 2024 | 0 | 159 | 7 |
| Nov 2024 | 0 | 52 | 2 |
| Dec 2024 | 0 | 44 | 2 |
| Jan 2025 | 0 | 74 | 5 |
| Feb 2025 | 0 | 83 | 5 |
| Mar 2025 | 0 | 41 | 1 |
Author:
Author:
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory